Trials / Conditions / Mycobacterium Avium Complex

Mycobacterium Avium Complex

10 registered clinical trials studyying Mycobacterium Avium Complex — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease NCT05824988	Shanghai Pulmonary Hospital, Shanghai, China	—
Recruiting	Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease NCT05192057	Radboud University Medical Center	Phase 4
Completed	A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF NCT04685720	Beyond Air Inc.	N/A
Terminated	Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium NCT04553406	Spero Therapeutics	Phase 2
Completed	A Study of Standard Drugs for Mycobacterium Avium Complex NCT04287049	Johns Hopkins University	Phase 2
Completed	Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease NCT03672630	Kevin Winthrop	Phase 2 / Phase 3
Active Not Recruiting	Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) NCT02968212	Oregon Health and Science University	Phase 2
Withdrawn	Improving Tolerance of Treatment of Pulmonary MAC Infections NCT01719042	University of Florida	Phase 2
Completed	Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung NCT00598962	The University of Texas Health Science Center at Tyler	Phase 4
Completed	Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM) NCT00600769	The University of Texas Health Science Center at Tyler	Phase 4